Narendra Wajapeyee
13PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Dec 09, 2025
Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression.Suresh Chava, Suresh Bugide, Parmanand Malvi
|Jun 30, 2025
NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degraders.Suresh Chava, Narendra Wajapeyee
|Mar 16, 2023
LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition.Parmanand Malvi, Dhana Sekhar Reddy, Raj Kumar
|Feb 28, 2023
Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy.Mehmet Akce, Bassel F El-Rayes, Narendra Wajapeyee
|Jan 18, 2023
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer.Suresh Bugide, Yvonne J K Edwards, Romi Gupta
|Jul 24, 2021
EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.Suresh Bugide, Romi Gupta, Michael R Green
Pageof 3
Frequent Collaborators
6 joint publications
Romi Gupta
3 joint publications
Parmanand Malvi
2 joint publications
Radoslav Janostiak
2 joint publications
Michael R Green
1 joint publications
Lili Pan
1 joint publications
Chao Hong
1 joint publications
Kohei Kume
1 joint publications
Vipin Rawat
1 joint publications
Eddy S Yang
1 joint publications
Yvonne J K Edwards
